Clinical Trials Browser

Phase 1 × Terminated × immunotoxin HA22 × Clear all

NCT01891981 2023-10-13

Study of Moxetumomab Pasudotox in Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia (ALL)

Phase 1 Terminated

LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00587457 2017-07-06

A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Participants With Chronic Leukemia

Phase 1 Terminated

11 enrolled 14 charts

LymphoidOther hematologic neoplasm

Cerebral Palsy, Leukemia, Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic

NCT00587015 2011-11-22

A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Patients With Non-Hodgkin's Lymphoma (NHL)

Phase 1 Terminated

Lymphoma